| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
CA: A Cancer Journal for Clinicians, Vol 42, Issue 3 181-191, Copyright © 1992 by American Cancer Society
I. J. Lerner and B. J. Kennedy
OBJECTIVE: To assess nationally the use of questionable cancer therapies.
DESIGN: Survey of cancer patients or their families regarding use of
questionable methods of cancer treatment; sample survey of physicians'
perception of use. PARTICIPANTS: 36,000 households; 5,047 individuals; 91
physicians. RESULTS: The prevalence of use of questionable cancer methods
was nine percent overall. An increase in use was directly proportional to
increased income and education. Prolonged illness and certain types of
cancer were more commonly associated with use. Harmful side effects of
questionable cancer treatments were regarded as modest (six percent). There
was a wide range in cost. Third-party reimbursement was reported by 25
percent of patients. Important discrepancies were found between patients'
and physicians' perceptions of questionable therapies. CONCLUSIONS: While
some questionable therapies are harmless or inexpensive, others have toxic
effects and may be costly, and none have scientifically proven efficacy.
Although the percentage of usage reported is relatively low, overall large
numbers of patients are involved, especially in certain groups. The
physician plays a key role in encouraging or preventing the use of
questionable methods, and substantial improvements in public and
professional education are needed.
ARTICLES
The prevalence of questionable methods of cancer treatment in the United States
University of Minnesota, Minneapolis.
This article has been cited by other articles:
|
|
 |
|
  H. Mukai, T. Watanabe, M. Ando, and N. Katsumata An Alternative Medicine, Agaricus blazei, May Have Induced Severe Hepatic Dysfunction in Cancer Patients Jpn. J. Clin. Oncol., December 1, 2006; 36(12): 808 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tascilar, F. A. de Jong, J. Verweij, and R. H. J. Mathijssen Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence Oncologist, July 1, 2006; 11(7): 732 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Dy, L. Bekele, L. J. Hanson, A. Furth, S. Mandrekar, J. A. Sloan, and A. A. Adjei Complementary and Alternative Medicine Use by Patients Enrolled Onto Phase I Clinical Trials J. Clin. Oncol., December 1, 2004; 22(23): 4810 - 4815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Boon, J. B. Brown, A. Gavin, and K. Westlake Men with Prostate Cancer: Making Decisions about Complementary/Alternative Medicine Med Decis Making, November 1, 2003; 23(6): 471 - 479. [Abstract] [PDF]
|
|
|
|
|
|
M. A. Gertz and B. A. Bauer Caring (Really) for Patients Who Use Alternative Therapies for Cancer J. Clin. Oncol., May 1, 2003; 21(90090): 125s - 128. [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Bausell and B. M. Berman Commentary: Alternative Medicine: Is It a Reflection of the Continued Emergence of the Biopsychosocial Paradigm? American Journal of Medical Quality, January 1, 2002; 17(1): 28 - 32. [Abstract] [PDF]
|
|
|
|
|
|
M. A. Gertz and B. A. Bauer Caring (Really) for Patients Who Use Alternative Therapies for Cancer J. Clin. Oncol., December 1, 2001; 19(23): 4346 - 4349. [Full Text]
|
|
|
|
|
|
M. A. Richardson, T. Sanders, J. L. Palmer, A. Greisinger, and S. E. Singletary Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology J. Clin. Oncol., July 1, 2000; 18(13): 2505 - 2514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Boon, M. Stewart, M. A. Kennard, R. Gray, C. Sawka, J. B. Brown, C. McWilliam, A. Gavin, R. A. Baron, D. Aaron, et al. Use of Complementary/Alternative Medicine by Breast Cancer Survivors in Ontario: Prevalence and Perceptions J. Clin. Oncol., July 1, 2000; 18(13): 2515 - 2521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Oneschuk, J Hanson, and E Bruera Complementary therapy use: a survey of community- and hospital-based patients with advanced cancer Palliative Medicine, July 1, 2000; 14(5): 432 - 434. [PDF]
|
|
|
|
 |
|
 M. M. Lee, S. S. Lin, M. R. Wrensch, S. R. Adler, and D. Eisenberg Alternative Therapies Used by Women With Breast Cancer in Four Ethnic Populations J Natl Cancer Inst, January 5, 2000; 92(1): 42 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Sabo, S. R. Michael, and L. L. Temple The Use Of Alternative Therapies by Diabetes Educators The Diabetes Educator, November 1, 1999; 25(6): 945 - 956. [PDF]
|
|
|
|
|
|
M. A. Richardson Research of Complementary/Alternative Medicine Therapies in Oncology: Promising but Challenging J. Clin. Oncol., November 1, 1999; 17(90001): 38 - 43. [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Burstein, S. Gelber, E. Guadagnoli, and J. C. Weeks Use of Alternative Medicine by Women with Early-Stage Breast Cancer N. Engl. J. Med., June 3, 1999; 340(22): 1733 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Warrick, J. C. Irish, M. Morningstar, R. Gilbert, D. Brown, and P. Gullane Use of Alternative Medicine Among Patients With Head and Neck Cancer Arch Otolaryngol Head Neck Surg, May 1, 1999; 125(5): 573 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Verhoef, N. Hagen, G. Pelletier, and P. Forsyth Alternative therapy use in neurologic diseases: Use in brain tumor patients Neurology, February 1, 1999; 52(3): 617 - 617. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
